Table 6.
Relationship between gender and age at first treatment with frequency of morbidity by individual health domain among respondents
| Health domain | Sex | Age at first treatment, y | |||||
|---|---|---|---|---|---|---|---|
| M (n = 115) No. (%) | F (n = 123) No. (%) | P* | ≤25 (n = 85) No. (%) | 26–35 (n = 89) No. (%) | >35 (n = 64) No. (%) | P† | |
| Vision | 18 (15.6) | 27 (22.0) | .25 | 11 (12.9) | 17 (19.1) | 17 (26.6) | .04 |
| Hearing | 13 (11.3) | 16 (13.0) | .70 | 7 (8.2) | 13 (14.1) | 9 (14.1) | .25 |
| Speech | 26 (22.6) | 39 (31.7) | .15 | 23 (27.1) | 27 (30.3) | 15 (23.4) | .68 |
| Cardiovascular | 64 (55.6) | 66 (53.7) | .80 | 42 (49.4) | 48 (53.9) | 40 (62.5) | .12 |
| Pulmonary | 20 (17.4) | 31 (25.2) | .16 | 15 (17.7) | 18 (20.2) | 18 (28.1) | .13 |
| Gastrointestinal | 24 (20.9) | 36 (29.3) | .19 | 22 (25.9) | 25 (28.1) | 13 (20.3) | .48 |
| Genitourinary | 1 (0.9) | 3 (2.4) | .62 | 2 (2.4) | 1 (1.1) | 1 (1.6) | .68 |
| Musculoskeletal | 38 (33.0) | 50 (40.7) | .23 | 24 (28.2) | 34 (38.2) | 30 (46.9) | .02 |
| Neurological | 13 (11.3) | 10 (8.1) | .51 | 8 (9.4) | 8 (9.0) | 7 (10.9) | .77 |
| Endocrine | 68 (59.1) | 95 (77.2) | .003 | 63 (74.1) | 68 (76.4) | 32 (50.0) | .003 |
| Psychiatric | 14 (12.2) | 39 (31.7) | <.001 | 25 (29.4) | 19 (21.4) | 9 (14.1) | .03 |
| Hematologic | 2 (1.7) | 9 (7.3) | .06 | 7 (8.2) | 1 (1.1) | 3 (4.7) | .24 |
| Dermatologic | 10 (8.7) | 44 (35.8) | <.001 | 21 (24.7) | 20 (22.5) | 13 (20.3) | .53 |
| Infectious disease | 31 (27.0) | 46 (37.4) | .10 | 27 (31.8) | 33 (37.1) | 17 (26.6) | .57 |
| Cancer | 20 (17.4) | 35 (28.5) | .05 | 20 (23.5) | 15 (16.9) | 20 (31.2) | .34 |
* Fisher’s exact test, two-sided.
† Mantel-Haenszel test for trend, two-sided.